| Literature DB >> 23028263 |
Lieven Huybregts1, Freddy Houngbé, Cécile Salpéteur, Rebecca Brown, Dominique Roberfroid, Myriam Ait-Aissa, Patrick Kolsteren.
Abstract
BACKGROUND: Recently, operational organizations active in child nutrition in developing countries have suggested that blanket feeding strategies be adopted to enable the prevention of child wasting. A new range of nutritional supplements is now available, with claims that they can prevent wasting in populations at risk of periodic food shortages. Evidence is lacking as to the effectiveness of such preventive interventions. This study examined the effect of a ready-to-use supplementary food (RUSF) on the prevention of wasting in 6- to 36-mo-old children within the framework of a general food distribution program. METHODS ANDEntities:
Mesh:
Year: 2012 PMID: 23028263 PMCID: PMC3445445 DOI: 10.1371/journal.pmed.1001313
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Figure 1Study flow chart.
Composition of a daily dose (46 g) of RUSF.
| Component | Amount |
| Weight of daily ration, g | 46 |
| Energy, kcal | 247 |
| Protein, g | 5.9 |
| Lipids, g | 16 |
| Linoleic acid, g | 2 |
| α-Linolenic acid, g | 0.3 |
| Vitamin A, µg | 400 |
| Vitamin E, mg | 6 |
| Thiamin, mg | 0.5 |
| Niacin, mg | 6 |
| Pantothenic acid, mg | 2 |
| Vitamin B-6, mg | 0.5 |
| Folic acid, µg | 160 |
| Vitamin B-12, µg | 0.9 |
| Vitamin C, mg | 30 |
| Magnesium, mg | 60 |
| Zinc, mg | 4 |
| Iron, mg | 9 |
| Copper, mg | 0.3 |
| Potassium, mg | 310 |
| Calcium, mg | 387 |
| Phosphorus, mg | 275 |
| Selenium, µg | 17 |
| Manganese, mg | 0.17 |
| Iodine, µg | 90 |
Child characteristics at inclusion by study arm.
| Characteristic | Control Arm | Intervention Arm |
|
| 7 | 7 |
|
| 440 (42.4) | 598 (57.6) |
|
| 1,427 | 2,199 |
|
| 24.2 (10.3) | 23.6 (9.9) |
|
| ||
| 6–11 mo | 78 (17.7) | 104 (17.4) |
| 12–17 mo | 63 (14.3) | 82 (13.7) |
| 18–23 mo | 51 (11.6) | 77 (12.9) |
| 24–29 mo | 78 (17.7) | 138 (23.1) |
| 30–36 mo | 170 (38.7) | 197 (32.9) |
|
| ||
| Male | 220 (50) | 299 (50) |
| Female | 220 (50) | 299 (50) |
|
| 9.6 (2.1) | 9.6 (2.1) |
|
| 79.9 (9.3) | 80.1(9.4) |
|
| 14.0 (1.0) | 14.0 (1.0) |
|
| −1.13 (0.76) | −1.12 (0.80) |
|
| −1.85 (1.43) | −1.65 (1.56) |
|
| ||
| WHZ<−2 | 59 (13.4) | 81 (13.6) |
| WHZ<−3 | 1 (0.2) | 3 (0.5) |
|
| ||
| HAZ<−2 | 198 (45.0) | 245 (41.0) |
| HAZ<−3 | 98 (22.3) | 106 (17.7) |
|
| 104 (17) | 104 (16) |
|
| 270 (61.5) | 370 (61.9) |
|
| ||
| Low | 151 (34.3) | 196 (32.8) |
| Average | 148 (33.6) | 198 (33.1) |
| High | 141 (32.1) | 204 (34.1) |
Data are mean (SD), unless stated otherwise.
Hemoglobin concentration was not measured in one child in the control group.
Effects of preventive RUSF on child anthropometry.
| Outcome | Control Arm ( | Intervention Arm ( |
|
|
| |||
| End point mean WHZ (SD) | −1.09 (0.95) | −1.05 (0.93) | |
| Intervention effect (95% CI), Z-score/mo | Reference | −0.002 (−0.032, 0.028) | 0.89 |
| Cumulative episodes WHZ<−2 | 174 | 241 | |
| Number of observed child-months | 1,427 | 2,199 | |
| Number of episodes per child-month (95% CI) | 0.12 (0.10, 0.14) | 0.11(0.09, 0.14) | |
| Incidence rate ratio (95% CI) | Reference | 0.86 (0.67, 1.11) | 0.25 |
|
| |||
| End point mean HAZ (SD) | −2.06 (1.39) | −1.79 (1.46) | |
| Intervention effect (95% CI), Z-score/mo | Reference | 0.03 (0.01, 0.04) | <0.001 |
| End point prevalence of stunting, percent ( | 52.3 (230) | 46.2 (276) | |
| OR of end point stunting (95% CI) | Reference | 0.69 (0.45, 1.07) | 0.099 |
|
| |||
| End point MUAC, cm (SD) | 14.1 (1.2) | 14.3 (1.1) | |
| Intervention effect (95% CI), cm/mo | Reference | 0.01 (−0.02, 0.04) | 0.49 |
Analyzed using a linear mixed model with random effects cluster, household, and child, adjusted for child's age at baseline, child's sex, SES, and baseline value.
Confidence intervals are estimated from a Poisson model adjusted for clustering.
Analyzed using a mixed Poisson regression model with random effects cluster, household, and child, adjusted for child's age at baseline, child's sex, SES, and baseline value.
Analyzed using a mixed logistic model with random effects cluster and household, adjusted for child's age at baseline, child's sex, SES, and baseline value.
Effect of preventive RUSF on child morbidity.
| Outcome | Control Arm ( | Intervention Arm ( |
|
| Number of child-months recalled | 333 | 513 | |
|
| |||
| Number of episodes | 388 | 416 | |
| Number of episodes per child-month (95% CI) | 1.17 (0.98, 1.39) | 0.81 (0.68, 0.97) | |
| Incidence rate ratio (95% CI) | Reference | 0.71 (0.63, 0.80) | <0.001 |
|
| |||
| Number of episodes | 448 | 548 | |
| Number of episodes per child-month (95% CI) | 1.35 (1.21, 1.50) | 1.07 (0.98, 1.17) | |
| Incidence rate ratio (95% CI) | Reference | 0.77 (0.70, 0.86) | <0.001 |
|
| |||
| Number of episodes | 231 | 328 | |
| Number of episodes per child-month (95% CI) | 0.69 (0.51, 0.95) | 0.64 (0.58, 071) | |
| Incidence rate ratio (95% CI) | Reference | 0.87 (0.76, 1.01) | 0.07 |
Calculated by number of recalls×recall duration.
Confidence intervals are estimated from a Poisson model adjusted for clustering.
Analyzed using a mixed Poisson regression model with random effects cluster, household, and child, adjusted for child's age at baseline, child's sex, SES, and morbidity status at baseline.
Effect of preventive RUSF on hemoglobin concentration and anemia at end point.
| Outcome | Control Arm ( | Intervention Arm ( |
|
| Hemoglobin concentration at end point (SD), g/l | 102.5 (15.2) | 105.8 (14.3) | |
| Intervention effect (95% CI), g/l | Reference | 3.8 (0.6, 7.0) | 0.02 |
| Number of anemic cases at end point (percent) | 273 (66.7) | 324 (56.5) | |
| OR of end point anemia | Reference | 0.52 (0.34, 0.82) | 0.004 |
End point hemoglobin values were unavailable for 31 and 25 participants from the control and intervention groups, respectively.
Analyzed using a linear mixed model with random effects cluster and household, adjusted for child's age at baseline, child's sex, SES, and hemoglobin concentration at baseline.
Analyzed using a mixed logistic regression model with random effects cluster and household, adjusted for child's age at baseline, child's sex, SES, and anemic status at baseline.